Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
about
Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterExpression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.Dendritic cell-based immunotherapy for malignant gliomas.Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer.Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasionImplications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma.Regulatory landscape and clinical implication of MBD3 in human malignant glioma.Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer.Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model.Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.PD-L1 expression in medulloblastoma: an evaluation by subgroup.MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.
P2860
Q24289417-3E9F9A5C-B272-4194-AE84-CF7ABBE3C8A5Q34696238-F2191D42-C1A0-4A56-8B06-C94B265FF057Q36198607-E0E8F674-0750-45A2-8BC6-A1A384C2ED8FQ36664277-AC26C852-83A1-4C7B-860A-B5D5B080C1B8Q36883024-40D1622D-D5E9-4F3B-8279-BBBB16776F5DQ37226831-46C180C1-952A-4EEF-8F20-C97DB797E3CEQ37684657-4FA9EFD4-87A8-4DC4-8712-18C1969B47FEQ37959304-3C79BD5A-90B2-44B5-9151-60180A512223Q38584881-6035BF6B-48A7-4B1F-95F6-BCA622582920Q42796699-E4E1F7C4-0C56-466D-B596-A4369A617A0DQ52714354-85187282-2A87-4365-BD1F-7EAA9F9CBAC3Q54705034-3F7CF1F3-4276-448D-BFA6-734E46287586
P2860
Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Malignant glioma cells use MHC ...... and CD4(+) T-cell activation.
@en
Malignant glioma cells use MHC class II transactivator
@nl
type
label
Malignant glioma cells use MHC ...... and CD4(+) T-cell activation.
@en
Malignant glioma cells use MHC class II transactivator
@nl
prefLabel
Malignant glioma cells use MHC ...... and CD4(+) T-cell activation.
@en
Malignant glioma cells use MHC class II transactivator
@nl
P2093
P2860
P356
P1433
P1476
Malignant glioma cells use MHC ...... g and CD4(+) T-cell activation
@en
P2093
A J Slavin
J C Patarroyo
J I Krieger
P A Nelson
S S Zamvil
P2860
P304
P356
10.1002/GLIA.1125
P50
P577
2001-12-01T00:00:00Z